Cite
HARVARD Citation
Koller, K. et al. (2017). Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone. Cancer biology & therapy. 18 (1), pp. 36-42. [Online].